Author: S. Owais Ahmad
Website:
Profile:
Owais has over five years of experience as fundamental credit analyst covering high yield and leveraged loans. Owais currently resides in New York.
Posts by S. Owais Ahmad:
SFD, Smithfield Foods Inc scores 3 on our checklist
Posted on 09. May, 2012 by S. Owais Ahmad.
Overall Score:3
Trading Chart +1
Smithfield is showing bullish RSI divergence but note the correlation with lean hog futures
which have fallen out of bed
Analyst Opinion: 1
Barron’s made the bull case in an April 11th article, titled Can Smithfield Foods go Hog Wild?
| Strong Buy | 5 | |
| Buy | 4 | |
| Hold | 6 | |
| Underperform | 0 | |
| Strong Sell | 0 | |
Insider Buying: 1
There was significant insider buying in Sept 11. Usually stocks are higher within six months. SFD was higher but collapsed under
sinking live hog prices.
Management Discussion and Analysis: 0
Company is subject to various federal, international and state regulation for safety and environmental reasons
Results are highly cyclical and very dependent on commodity prices for feedstock, hog prices, fuel, packaging etc
Outbreak of disease and health scares will negatively impact results
Company is vulnerable to various health risks associated with the food industry
GIPSA proposed rule will negatively impact relationships with hog producers and customers
Company has high indebtedness, covenants associated with the credit facilities
Multiple lawsuits pending (totalling $15-30mm)
FY11 Pork segment operating profit increased by $214.7mm as a result of higher fresh pork prices (which more than offset higher raw materials)
FY11 Hog segment operating profit increased by $763mm due to a 29% increase in domestic market live hog prices
Widespread Ethanol15 use is increasing prices of livestock feed.
YTD 3Q12 sales increased primarily due to the Pork segment were ASPs increased 9% due to higher market prices for fresh pork and and improved sales mix in packaged meats
Gross Margins were negatively impacted due to higher raw material costs, Live hog prices increased to $66/cwt from $55. Raising costs increased to $64/cwt from $53 as a result of higher feed prices
Outlooks looks to be stable, with operating margins in packaged meats to average 10-15 cents / lbs. Hog production margins should average between $10-15 per head
$300mm CAPEX over the next 5-7 years to move to group pens from gestation stalls
23,000 employees under CBA, 3,700 whose CBA expires in 2012, relations are good
Liquidity is adequate, $925mm revolver, $275mm receivables facility,
Company has been redeeming debt as part of its debt reduction programs
Company has $506mm (as of 1/29/12) in investments in joint ventures and equity in various companies
Company is underfunded $373 million. Company contributes $100 million a year to pension fund
Stock Performance relative to the Market: -1
Sector Outlook: 1
Management is optimistic on the pork and hog producing segment, feel that they have a very good handle on margins
Cash Flow: 0
| May Year End | Yearly | YTD | LTM | ||||
| 2009 | 2010 | 2011 | 01/30/11 | 01/29/12 | 01/29/12 | ||
| Revenues | $12,488 | $11,203 | $12,203 | $9,086 | $9,885 | $13,002 | |
| COGS | 11,863 | 10,473 | 10,489 | 7,829 | 8,679 | 11,339 | |
| Gross Profit | 625 | 730 | 1,714 | 1,258 | 1,207 | 1,663 | |
| SG&A | 798 | 706 | 790 | 594 | 627 | 823 | |
| EBIT | (174) | 24 | 924 | 663 | 580 | 841 | |
| D&A | 271 | 242 | 232 | 174 | 182 | 240 | |
| EBITDA | 97 | 267 | 1,156 | 838 | 762 | 1,081 | |
| Capex | (179) | (175) | (177) | (112) | (199) | (264) | |
| Interest | (222) | (266) | (245) | (135) | (194) | (305) | |
| Working Capital | 290 | 58 | (34) | 29 | (150) | (213) | |
| Taxes | 33 | 149 | (78) | (190) | (140) | (28) | |
| FCF | 18 | 32 | 622 | 429 | 79 | 272 | |
| CFO | 270 | 258 | 616 | 391 | 211 | 437 | |
| CFI | 441 | (134) | 254 | 281 | (189) | (216) | |
| CFF | (674) | 209 | (946) | (542) | (228) | (632) | |
| Net Income | (198) | (101) | 521 | 423 | 282 | 380 | |
PEG Ratio: -1
| P/E | 8.78 | |||
| 2012 | 2013 | |||
| EPS | 2.69 | 2.79 | 3.7% | |
| PEG Ratio | 2.36x |
Valuation: 1
Value Pro shows a 88% upside from the current price of $20.16
Adjusted FCF for 7 yrs from 10 yrs
Adjusted growth rate to 5%
10 yr treasury at 3%
Company interest rate is approximately 7%
Equity risk premium assumed at 5%
Beta is taken from finance.yahoo
Adjusted investment rate to account for pension payments
Catalyst: 0
Hog price stabilization, increase in demand for packaged meats, lower feedstock prices
NLY, Annaly Capital Management scores low inspire of being a Cramer have
Posted on 17. Apr, 2012 by S. Owais Ahmad.
Overall Score: 1
Trading Chart: 1
Analyst Opinion: -1
| Strong Buy | 0 | |
| Buy | 7 | |
| Hold | 16 | |
| Underperform | 0 | |
| Strong Sell | 0 | |
Insider Trading: 1
Large purchase Kevin Keyes on 8-8-11 of 50,000 shares at $17.13. Numerous exercises without evidence of sales, quite bullish considering the negative tax implications of exercising stock and not selling sufficient amount to pay taxes.
Management Discussion and Analysis: 0
Company is extremely vulnerable to changes in financial market conditions and liquidity in mortgage related assets
The potential limiting / winding down of Fannie and Freddie will negatively impact securities NLY invests in
A considerable portion of assets are guaranteed by Freddie and Fannie which may be jeapordized depending on the Government’s role
Prepayment rates might rise depending on various Government loan programs negatively impacting income
European crisis will have a negative impact on liquidity for assets NLY is invested in as well as financing provided by various affected banks
NLY relies on short term borrowings to invest in longer term assets
Current debt:equity leverage is 5.4:1 (target is between 8 and 12:1)
Counterparty risk in repurchase transactions
NLY investments are subject to credit risk. At least 75% of securities must be high quality MBS and short term investments. The remaining 25% have to BBB or higher. The portfolio is structured to maintain at least an overall rating of “A”
NLY is subject to various REIT and REIT related tax legislation
Authorized capital stock doubled from 1,000,000,000 to 2,000,000,000
Company is exempt from being regulated as an investment company, but the SEC is considering making changes to prevent this
Net Income dropped to $344.5mm as a result of a $1.8bn unrealize loss on interest rate swaps.
Economic Net Interest income rose $697 mm as interest earning assets rose $29.7bn with interest bearing liabilities rising $24.2bn
Average prepayment rates were 17%, 27% and 19% in 2011, 2010 and 2009
Stock Performance Relative to Market: -1
Sector Outlook: 0
Cash Flow: 0
| 2009 | 2010 | 2011 | ||||
| Interest Income | $3,580 | $2,683 | $2,923 | |||
| Interest Expense | (480) | (428) | (576) | |||
| Net Interest Income | 3,099 | 2,255 | 2,347 | |||
| Other Income | 238 | 271 | 152 | |||
| Realized Gains (losses) on swaps | (882) | (735) | (720) | |||
| Unrealized Gains (losses) on swaps | (1,815) | (319) | 350 | |||
| Expenses | (237) | (172) | (132) | |||
| EBIT | 402 | 1,300 | 1,996 | |||
| Amortization | 794 | 664 | 253 | |||
| EBITDA | 1,196 | 1,964 | 2,249 | |||
| Unrealized Gains (losses) on swaps | 1,815 | 319 | (350) | |||
| Taxes | (61) | (37) | (42) | |||
| FCF | 2,951 | 2,246 | 1,857 | |||
| CFO | 2,420 | 10,863 | 10,817 | |||
| CFI | (25,120) | (13,846) | (7,338) | |||
| CFF | 23,411 | 1,761 | 2,885 | |||
| Net Income | 344 | 1,267 | 1,961 | |||
Peg Ratio: 1
| P/E | 42.54 | |||
| 2011 | 2012 | |||
| EPS | 0.37 | 1.93 | 421.6% | |
| PEG Ratio | 0.10x |
Valuation: 0
Value Pro Valuation will not work with a REIT
Catalyst:
Interest Rate Stability, Economic and Political Stability, Recovery in mortgage market
Revision 5-19 Score is negative now.CALL, magicJack Vocal Tec Ltd Snapshot scores high at 7 of 10
Posted on 17. Apr, 2012 by S. Owais Ahmad.
Overall Score: 7
Trading Chart: 0
The chart is neutral to me at the moment.
Analyst Opinion: 1
| Strong Buy | 1 | |
| Buy | 1 | |
| Hold | 0 | |
| Underperform | 0 | |
| Strong Sell | 0 | |
Insider Trading: 1
Recent insider buy at by Dir Ventor of 22,000 at $23.07 on 4/13/12 is a strong endorsement
Management Discussion and Analysis: 1
Potential E911 regulation fees for nomadic VOIP providers
Network Neutrality is key in the Company being able to provide it’s services to customers
Change in contributions to USF will negatively impact net income
Continued product and service innovation will be require to grow revenue
Company’s product are subject to intellectual property infringement
Majority of sales are through independent retailers
As a CLEC the Company is subject to changing regulation
Company purchases switching elements that are key to its operations from it’s competitors
Broadband telephone service is growing and as such is not subject to regulation, but this might change in the future
Privacy and online security risks are a concern
Israeli Company, therefore certain US laws and judgements may not be enforceable
Potential lawsuit against 3 telecoms for $25.9mm in access services rendered being debated by federal courts, clarified by FCC rulings
Revenues in 2011 were lower as a result of lower unit sales, lower access and termination charge revenue (related to FCC ruling), partially offset by higher renewal revenues, related products and prepaid minutes
Direct sales were 43%, 27% and 35% in 2011, 2010 and 2009
Company is guiding to 20-30% revenue growth, $1.25-$1.50 2012 EPS an $2.00-$2.25 2013 EPS
Share buyback to resume, increased by $20mm
Stock Performance relative to Market: 1
Sector Outlook: 1
Good revenue outlook, increased clarity on billing for accessed services, new product introductions and product maturity should provide revenue stability and growth
Cash Flow: 1
Cash flow is higher than net income, primarily because of a recent FCC ruling and large amounts of deferred revenue
| 2009 | 2010 | 2011 | ||
| Revenues | $116.8 | $119.7 | $110.5 | |
| COGS | 63.1 | 57.2 | 51.2 | |
| Gross Profit | 53.7 | 62.5 | 59.3 | |
| SG&A | 78.4 | 64.8 | 63.9 | |
| EBIT | (24.7) | (2.3) | (4.6) | |
| Stock Comp | 0.3 | 5.1 | 2.4 | |
| Doubtful Accounts | 1.6 | 6.7 | 16.4 | |
| D&A | 2.9 | 2.9 | 4.2 | |
| EBITDA | (19.9) | 12.4 | 18.4 | |
| Capex | (0.8) | (2.6) | (1.0) | |
| Working Capital | 44.5 | 9.4 | 5.5 | |
| FCF | 23.8 | 19.2 | 22.9 | |
| CFO | 23.9 | 23.4 | 25.3 | |
| CFI | (9.5) | 0.1 | (9.0) | |
| CFF | (4.0) | (8.2) | (32.0) | |
| Net Income | (0.8) | (1.6) | (22.5) | |
PEG Ratio: 1
| Forward P/E | 19.37 | |||
| 2012 | 2013 | |||
| EPS | 1.27 | 2.25 | 77.2% | |
| PEG Ratio | 0.25x | |||
Valuation: -1
Value Pro shows a 24% downside from the current price of $23.85
Adjusted FCF for 4 yrs from 10 yrs
Adjusted growth rate to 25%
10 yr treasury at 3%
Adjusted NOP%, tax rate, depreciation and investment rate
Equity risk premium assumed at 5%
Beta is taken from finance.yahoo
Catalyst: 1
Increased consumer adoption rates, increased product offerings, increased stability with regulation and rate determination
PMC, PharMerica Corporation will be proven right turning down $15 from Omnicare
Posted on 13. Apr, 2012 by S. Owais Ahmad.
Overall Score: 3
Chart: 1
Analyst Opinion: -1
| Strong Buy | 1 | |
| Buy | 1 | |
| Hold | 6 | |
| Underperform | 0 | |
| Strong Sell | 0 | |
Insider Trading: 1
Management Discussion and Analysis: 0
Omnicare withdrew from their hostile takeover offer at $15 share after FTC moved to block the takeover
Government and Regulation risk is high
Shift from Branded to Generic drugs is resulting in accelerating margin compression
Pharmacies are subject to federal and state laws regulating financial relationships with healthcare providers
Pharmacies are licensed and are regulated under the DEA and FDA
These laws and regulations may impact business practices (anti kickback,Stark laws)
Recent Healthcare legislation may impact reimbursement rates for drugs sold
Company is subject to HIPAA
Company might be subject to shareholder lawsuits relating to failed takeover by Omnicare
Reduction in manufacturer’s rebate will have a negative impact on margins
Continuing efforts to contain healthcare costs are likely to impact margins negatively
Kindred provides all of the Company’s Information services, potential for cost increases
Growth in 2011 sales was primarily due to acquisitions. Volume and pricing improved and was partially offset by increased generic sales and pricing concessions
Gross margins improved as a result of improved rebates under a new vendor agreement
Company guided to lower revenue at $1.9-1.95bn, with EBITDA at $93-102mm
Stock Performance Relative to Market: -1
Sector Outlook: 0
Healthcare sector is up 10%YTD, Overall stable outlook, it would seem that the regulation risk is low-minimal for now.
Free Cash Flow: 1
Cash flow is growing, and adjusted for one time payments aggregating $99.7mm, CFO in 2011 would have been $126.5mm
| 2009 | 2010 | 2011 | ||||||||
| Revenues | $1,841.2 | $1,847.3 | $2,081.1 | |||||||
| COGS | 1,565.7 | 1,607.0 | 1,787.8 | |||||||
| Gross Profit | 275.5 | 240.3 | 293.3 | |||||||
| Amortization | 9.0 | 9.3 | 11.0 | |||||||
| G&A | 190.8 | 180.6 | 214.9 | |||||||
| EBIT | 75.7 | 50.4 | 67.4 | |||||||
| D&A | 27.0 | 28.1 | 31.1 | |||||||
| EBITDA | 102.7 | 78.5 | 98.5 | |||||||
| Capex | (21.6) | (12.6) | (13.2) | One time cash flow items | 2011 | |||||
| Interest | (11.2) | (3.2) | (7.6) | AmeriBergen extra Friday payment | 29.6 | |||||
| Working Capital | (9.3) | 32.3 | (55.2) | Inventory increase to improve margins | 57.4 | |||||
| Taxes | (1.6) | (0.4) | (0.5) | ChemRx acquisition adjustment | 12.7 | |||||
| FCF | 59.0 | 94.6 | 22.0 | Total | 99.7 | |||||
| CFO | 85.0 | 98.2 | 26.8 | |||||||
| CFI | (76.1) | (133.2) | (64.0) | |||||||
| CFF | 1.0 | (5.4) | 43.8 | |||||||
| Net Income | 42.2 | 19.2 | 23.4 | |||||||
PEG Ratio: 1
| P/E | 15.32 | ||
| 2011 | 2012 | ||
| EPS | 0.79 | 1.19 | |
| PEG Ratio | 0.30x |
Valuation: 1
Adjusted FCF for 7 yrs from 10 yrs
Adjusted growth rate to 1%
10 yr treasury at 3%
Investment rate is adjusted higher to closer match depreciation rate
Equity risk premium assumed at 5%
Beta is taken from finance.yahoo
Catalyst: 0
Reversal on healthcare cost controls, increased manufacturer’s rebates
VRX, Valeant Pharmaceuticals remains a mystery. What does the CFO see?
Posted on 13. Apr, 2012 by S. Owais Ahmad.
Overall Score:
Trading Chart: 0
Analyst Opinion: 1
| Strong Buy | 5 | |
| Buy | 10 | |
| Hold | 3 | |
| Underperform | 1 | |
| Strong Sell | 0 | |
Insider Trading:1
Insiders definitely see some potential here leading off with the CFO Schiller’s apprarent open market purchase of 27,800 at $53.64 between 3-1 and 3-12
Management Discussion and Analysis: 1
Government regulation risk is high
Significant product liability risk
2012 guidance for revenue in the $3.1-$3.4bn range
Company merged with Biovail in Sep 2010
Company claims 9% organic growth in 2011. Results are murky due to the multiple acquisitions
US Neuro Volume was down 12%, but was partially offset by price increase of 8%
Other segments showed strong growth both in volume and price
4,100 SKUs, Wellbutrin 9% of sales, Zovirax 8%. Wellbutrin to continue to decline due to generic erosion
Mckesson (23%), Cardinal Health (21%), and AmerisourceBergen Corporation (10%) are top 3 customers
Continued R&D is needed to help offset declining sales once patent’s expire
Company is extremely acquisitive and has been a major source of growth
12/21/2011: Acquired iNova for $657mm, fair value of $44.5mm in contingent payments
12/16/2011: Acquired Dermik for $420.5mm
12/12/2011: Acquired OrthoDermatologics division of Janssen Pharmaceuticals for $346.1mm
10/17/2011: Acquired 74% of Afexa for $67.7mm, Acquired remaining shares for $22.5mm
08/19/2011: Acquired 87.2% of Sanitas for $392.3mm, Acquired remainder for total purchase price of $448.2mm
June 2011: Acquired exclusive rights to commercialize Elidel and Xerese cream for fair value of $437.7mm
Feb / Mar 2011: Acquired US and Canadian rights to Zovirax for $300mm
Mar 2011: Acquired PharmaSwiss for $491.2mm
Company has $6.65bn in debt
Forex risk, Company estimates that a 1% change in FX rates will impact shareholders equity by $35mm
Regulation Risk includes drug approval, sales practices and medicare rebates
Securities Purchasing Program authorizes upto $1.5bn in capital structure retirement
US Healthcare reform has potential to impact the Company negatively. Company has not quantified the impact
$275mm credit facility, $570mm in cash
Stock Performance relative to market: 0
Sector Outlook: 1
Positive, growth amongst all sectors driven by acquisitions. Negative overhang from healthcare regulation
Cash Flow: 0
Cash flow is difficult to determine given the rapidly changing nature of the Company through acquisitions
| 2009 | 2010 | 2011 | ||
| Revenues | $820.4 | $1,181.2 | $2,463.5 | |
| COGS | 204.3 | 395.6 | 683.8 | |
| Operating Expenses | 435.0 | 895.7 | 1,479.7 | |
| EBIT | 181.2 | (110.1) | 300.0 | |
| D&A | 149.3 | 254.5 | 612.6 | |
| EBITDA | 330.4 | 144.4 | 912.6 | |
| CFO | 360.9 | 263.2 | 676.5 | |
| CFI | (742.8) | 228.9 | (2,844.5) | |
| CFF | 177.0 | (213.3) | 1,948.2 | |
| Net Income | 176.5 | (208.2) | 159.6 | |
Peg Ratio: 0
Not Applicable since we have no EPS estimates for 2012
Valuation: 0
Given the rapidly changing nature of the Company (through acquisitions) ValuePro would not provide an accurate valuation for the stock.
Catalyst: 0
Continued acquisitions, good pipeline management, succesfull drug development
CAKE, Cheesecake Factory is tasty but leaves one hungering for more
Posted on 13. Apr, 2012 by S. Owais Ahmad.
Overall Score:0
Trading Chart: 0
Analyst Opinion: 0
| Strong Buy | 5 | |
| Buy | 5 | |
| Hold | 17 | |
| Underperform | 1 | |
| Strong Sell | 0 | |
Insiders: 1
Director Simon persistent buyer
Management Discussion and Analysis: 0
Government and Health Safety Risk is High
Comp sales rose 2% driven by increased traffic, and higher average checks which included pricing increases
Cost of sales increased 60bps to 25.5% due to higher dairy and grocery prices
International Expansion risk (22 stores over 5 years) which is concentrated in the MENA region
170 total restaurants, 11 new expected in 2012, 3 internationally
Sales / sq ft have been $864, $850, 830 in 2011, 2010, 2009
New Store spend is $650-750 / sq ft
Company does not use a centralized food purchasing system relying instead on local and regional suppliers
Marketing and Advertising spend is ~1% of sales as a result of focused and selective approaches
Results are seasonal with 2Q and 3Q and last two weeks of 4Q being revenue intensive
Revenues are highly dependent on consumer’s discretionary income
Exposed to rising food and dairy costs for which effective hedging is not possible
Negative publicity risk
Regulations include wage rules, health insurance provision, worker safety, alcohol permits
Caloric reporting requirements could negatively impact sales
Healthcare costs are rising, not quantified as yet but will squeeze margins
Company carries insurance for protection against various lawsuits
$200mm credit facility maturing in Dec 2015
Board of Directors has a poison pill
Capex to be running higher than average going forward, $100-110mm in 2012
8.8mm share repurchase authorized outstanding
Stock Performance Relative to Market: 0
Sector Outlook: 1
Consumer discretion 3rd best performing sector YTD up 14.48% versus 10.33% for S&P 500 Relatively neutral, with moderating demand from consumers, risk from rising food prices and declining economic environment
Cash Flow: 0
Cash flow is relatively stable, but new restaurant openings, refreshes and expansion requires higher capex resulting in declining free cash flow going forward
| 2009 | 2010 | 2011 | ||
| Revenues | $1,602.0 | $1,659.4 | $1,757.6 | |
| COGS | 394.4 | 412.9 | 448.5 | |
| Labor Expenses | 528.6 | 537.0 | 567.4 | |
| Other Opex | 406.2 | 413.5 | 438.6 | |
| Gross Profit | 272.9 | 296.1 | 303.2 | |
| D&A | 75.2 | 72.1 | 72.0 | |
| G&A | 96.3 | 95.7 | 97.4 | |
| EBIT | 101.4 | 128.2 | 133.8 | |
| D&A | 75.2 | 72.1 | 72.0 | |
| EBITDA | 176.6 | 200.3 | 205.8 | |
| Capex | (37.2) | (41.8) | (76.7) | |
| Interest | (24.5) | (17.5) | (4.3) | |
| Working Capital | 0.3 | (7.2) | (9.8) | |
| Taxes | (18.6) | (31.0) | (27.2) | |
| FCF | 96.6 | 102.7 | 87.7 | |
| CFO | 198.8 | 167.1 | 196.1 | |
| CFI | (77.6) | (43.7) | (74.7) | |
| CFF | (167.5) | (115.5) | (151.9) | |
| Net Income | 42.8 | 81.7 | 95.7 | |
PEG Ratio: -1
| P/E | 18.1 | |||
| 2011 | 2012 | |||
| EPS | 1.64 | 1.86 | 13.4% | |
| PEG Ratio | 1.35x |
Valuation: -1
Value Pro shows a 22% downside from the current price of $29.70
Adjusted FCF for 7 yrs from 10 yrs
Adjusted growth rate to 5%
10 yr treasury at 3%
Investment Rate is adjusted to reflect higher CAPEX
Equity risk premium assumed at 5%
Beta is lowered to accurately reflect a lower cost of capital
Catalyst: 0
Dairy and Produce price stabilization, consumer confidence and disposable income needs to improve
RYN, Rayonier Inc. Snapshot
Posted on 13. Apr, 2012 by S. Owais Ahmad.
Overall Score: 6
Trading Chart: 1
Analyst Opinion: 1
| Strong Buy | 3 | |
| Buy | 2 | |
| Hold | 2 | |
| Underperform | 1 | |
| Strong Sell | 0 | |
Insider Trading: 1
Director Brown bought 17,000 shares at 44.26
Management Discussion and Analysis: 1
Sales benefited from price and volume increase in timber. Cellulose sales were strong with an increase in volume and price
Absorbent materials sales were stagnant as higher prices offset lower volume
Housing activity is a key driver for lumber demand
Eastman Chemical (15%), Celanese (11%) and Nanton Cellulose (11%) are top 3 customers
Union agreement for 700 employees (out of 1900) expires in June 2012
Commodity price risk (oil, natural gas and chemicals)
EPA and government regulation changes would negatively impact operating results
Environmental groups can curtail operations
Company is undertaking a $300mm project expanding it’s Jessup facility (performance fibers)
Company is focused on timberland acquisitions
$450mm credit facility maturing in 2106
Company has $847mm in debt
$117mm underfunded pension plan
Stock Performance Relative to Market: 1
Sector Outlook: 1
Long term fundamentals remain strong, 2012 volumes to improve over 2011 in timber and performance fiber with weakness in absorbent materials
Cash Flow: 1
Free cash flow (ex-acquisitions) is stable, but will be negatively impacted in 2012 due to higher CAPEX
| 2009 | 2010 | 2011 | ||
| Revenues | $1,169 | $1,315 | $1,489 | |
| COGS | 915 | 990 | 1,074 | |
| Gross Profit | 254 | 325 | 415 | |
| SG&A | 63 | 67 | 67 | |
| EBIT | 191 | 258 | 348 | |
| D&A | 158 | 143 | 136 | |
| EBITDA | 350 | 401 | 484 | |
| Capex | (92) | (138) | (145) | |
| Interest | (52) | (50) | (51) | |
| Working Capital | (30) | (12) | (9) | |
| Taxes | (46) | (15) | (30) | |
| FCF | 129 | 186 | 249 | |
| CFO | 307 | 495 | 432 | |
| CFI | (93) | (143) | (489) | |
| CFF | (202) | (78) | (215) | |
| Net Income | 331 | 229 | 231 | |
PEG Ratio: -1
| 4/11/2012 | |||
| P/E | 19.8 | ||
| 2011 | 2012 | ||
| EPS | 2.2 | 2.5 | |
| PEG Ratio | 1.45x |
Valuation: -1
Value Pro shows a 23% downside from the current price of $43.5.
Adjusted FCF for 7 yrs from 10 yrs
Adjusted growth rate to 10%
10 yr treasury at 3%
Company interest rate is 6%
Equity risk premium assumed at 5%
Beta is taken from finance.yahoo
Catalyst: 1
Stronger than expected pickup in home building activity will increase volume and pricing for timber sales
FDP Fresh Del Monte Produce Snapshot
Posted on 11. Apr, 2012 by S. Owais Ahmad.
Overall Score: 1
Chart: 1
Analyst Opinion: -1
| Strong Buy | 1 | |
| Buy | 0 | |
| Hold | 4 | |
| Underperform | 1 | |
| Strong Sell | 0 | |
Insiders: 1
CEO Amir Abu-Ghazela buys 100,000 shares at 22.59 between 3-1-12 and 3-6-12.
Management Discussion and Analysis: 0
Government and Regulation Risk
Natural Disaster Risk
Sales rose slightly largely due to higher prices, partially offset by lower volumes
Gross margins improved slightly because of higher sale prices, partially offset by higher fuel costs
Higher SG&A expenses due mainly to increased selling and mkting expenses in South Europe
Fuel costs rose 37% ($38.6mm), container board dropped 8%, charter rates stable
48% from Company owned farms, 35% from Costa Rica
Bananas are 46% of sales
#3 in Banana, #1 in Pineapples, fragmented mkt share elsewhere
Walmart 12% of sales, top 10 is 32% of sales
Low barriers to entry, distribution and logistics network is competitive advantage
EU has tariffs on Banana import till 2020, might change structure
No material environmental proceedings
Seasonality, 1Q highest margins, 2Q highest revenues
Good labor relations
Currency exposure is hedged
Southern Europe dist and marketing is new and untested
Abu Ghazaleh family owns 34% of shares
$300mm credit facility maturing in 2013 (downsized from $500mm), MGT happy with liquidity
$590mm tax loss carry forwards
No PENSION or OPEB risk
Multiple lawsuits / antitrust pending ($30mm+)
EPA cleanup costs ~$20mm over 10 years
Stock performance relative to Market: -1
Sector Outlook: -1
High commodity prices, minimal pricing controls point towards compressing margins, negative economic outlook for consumer
Cash Flow: 0
Cash flow is relatively stable, working capital has been a source of cash in the past 3 years
| 2009 | 2010 | 2011 | ||
| Revenues | $3,496.4 | $3,552.9 | $3,589.7 | |
| COGS | 3,185.6 | 3,280.5 | 3,270.2 | |
| Gross Profit | 310.8 | 272.4 | 319.5 | |
| SG&A | 165.8 | 166.8 | 190.4 | |
| EBIT | 145.0 | 105.6 | 129.1 | |
| D&A | 83.7 | 78.7 | 73.5 | |
| EBITDA | 228.7 | 184.3 | 202.6 | |
| Capex | (84.5) | (70.8) | (79.4) | |
| Interest | (11.9) | (10.8) | (6.8) | |
| Working Capital | 27.5 | 22.3 | 10.2 | |
| Taxes | (18.1) | (3.3) | (11.2) | |
| FCF | 141.7 | 121.7 | 115.4 | |
| CFO | 257.5 | 197.4 | 195.7 | |
| CFI | (66.9) | (50.6) | (74.7) | |
| CFF | (182.2) | (136.7) | (125.7) | |
| Net Income | 144.6 | 60.8 | 94.8 | |
PEG Ratio: 1
| P/E | 14.25 | |||
| 2011 | 2012 | |||
| EPS | 1.56 | 1.93 | 23.7% | |
| PEG Ratio | 0.60x |
Valuation: 1
Value Pro shows a 65% upside from the current price of $22.27
Following changes were made to Value Pro’s assumptions:
Adjusted FCF for 7 yrs from 10 yrs
Adjusted growth rate to 1.5%
10 yr treasury at 3%
Company interest rate is 1.75%
Equity risk premium assumed at 5%
Beta is taken from finance.yahoo
Catalyst: 0
Commodity price stabilization, Consumer confidence and disposable income needs to improve
HAL, Halliburton Company Snapshot
Posted on 11. Apr, 2012 by S. Owais Ahmad.
Overall Score: 6
Chart: 1
Analyst Opinion: 1
| Strong Buy | 12 | |
| Buy | 21 | |
| Hold | 2 | |
| Underperform | 0 | |
| Strong Sell | 0 | |
Insiders: 1
Director Gerber bought 30,000 shares at $36.84
Management Discussion and Analysis: 0
Government, Political, Environmental and Regulation Risk is very high
Catastrophe / Accident Risk is high
Sales rose significantly due to higher rig count and demand for services particularly in NA
Operating Income increased due to improved demand and pricing particularly in the Completion and Production segment
Corporate expenses increased due to higher legal expenses
Demand for oil and gas determine end demand for Company services
End demand is directly impacted by Customer’s capex levels
Venezuelan operations are at high risk depending on Venezuelan govt sentiment
EPA / State regulations on hydraulic fracturing may negatively impact demand for those services
55% revenues from the US, no other country is more than 10% of sales
Defendant in Deepwater Horizon accident, no charges taken so far
Increased regulations may result in higher operating costs
Insurance costs and availability has worsened as a result of the Deepwater Horizon accident
SEC lawsuit related to accounting measures for recognizing revenue
$2bn credit facility maturing in 2016 and $2.7bn in cash ($500mm overseas)
No PENSION or OPEB risk
Stock Performance relative to Market: -1
Sector Outlook: 1
Long term fundamentals remain strong, short-intermediate period natural gas demand (through rigs is low). Hydraulic fracturing demand is strong but coming under margin pressure as companies turn away from dry gas and compete in oily sector. A lot of this will hinge on how easily oil can be transported out of North Dakota by pipeline.
Cash Flow: 0
Cash flow fluctuates significantly, due largely to volatile swings in demand impacting working capital and CAPEX
| 2009 | 2010 | 2011 | ||
| Revenues | $14,675 | $17,973 | $24,829 | |
| COGS | 12,474 | 14,735 | 19,811 | |
| Gross Profit | 2,201 | 3,238 | 5,018 | |
| SG&A | 207 | 229 | 281 | |
| EBIT | 1,994 | 3,009 | 4,737 | |
| D&A | 931 | 1,119 | 1,359 | |
| EBITDA | 2,925 | 4,128 | 6,096 | |
| Capex | (1,864) | (2,069) | (2,953) | |
| Interest | (285) | (297) | (263) | |
| Working Capital | 454 | (656) | (649) | |
| Taxes | (518) | (853) | (1,439) | |
| FCF | 712 | 253 | 792 | |
| CFO | 2,406 | 2,212 | 3,684 | |
| CFI | (3,085) | (1,755) | (3,190) | |
| CFF | 1,670 | (1,114) | 833 | |
| Net Income | 1,155 | 1,842 | 2,844 | |
PEG Ratio: 1
| P/E | 10.44 | |||
| 2011 | 2012 | |||
| EPS | 3.08 | 3.75 | 21.8% | |
| PEG Ratio | 0.48x |
Valuation: 1
Value Pro shows a 61% upside from the current price of $32.12.
Adjusted FCF for 7 yrs from 10 yrs
Adjusted growth rate to 8%
10 yr treasury at 3%
Company interest rate is 5.5%
Equity risk premium assumed at 5%
Beta is lowered to more accurately reflect low interest rates and a long term WACC
Catalyst: 1
Elimination of doubt relating to liabilities related to the Deepwater Horizon accident, Reduced regulation on hydraulic fracturing, Rebound in natural gas rig count





























